METHOD FOR THE DETERMINATION OF GLYCATED HEMOGLOBIN

Details for Australian Patent Application No. 2002256540 (hide)

Owner THERASENSE, INC.

Inventors HELLER, Adam

Pub. Number AU-A-2002256540

PCT Pub. Number WO2002/093152

Priority 60/291,361 16.05.01 US; 60/377,886 02.05.02 US; 10/146,577 14.05.02 US

Filing date 15 May 2002

Wipo publication date 25 November 2002

International Classifications

G01N 027/327 Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means - Biochemical electrodes

G01N 033/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

C12Q 001/26 Measuring or testing processes involving enzymes or micro-organisms - involving oxidoreductase

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-A-2002256540

4 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256541-BRASSIERE ESPECIALLY FOR LACTATING MOTHERS

2002256539-METHOD AND SYSTEM FOR CREATING PERVASIVE COMPUTING ENVIRONMENTS